Mitochondrial Dysfunction And Cellular Senescence Drive Accelerated Gestational Aging In Spontaneous Preterm Birth: A Narrative Review
For millions of families worldwide, the early arrival of a baby, known as spontaneous preterm birth, is a significant concern, leading to serious health challenges for newborns. Despite advancements in medical care, the underlying reasons for why some babies arrive too soon have remained largely a mystery. While infections and inflammation have long been considered culprits, they don’t fully explain every case.
Recent research suggests a new perspective: that early births might be a result of the “accelerated aging” of the tissues involved in pregnancy. Imagine the body’s cells, particularly those in the placenta and surrounding membranes, showing signs of wear and tear much earlier than they should. This premature aging is linked to two key cellular processes: problems with mitochondria and cellular senescence.
Mitochondria are often called the “powerhouses” of our cells, responsible for generating the energy needed for all bodily functions. When these powerhouses don’t work correctly, it leads to a state called mitochondrial dysfunction. This can result in an increase of harmful molecules called reactive oxygen species, which essentially cause “oxidative stress” or rust-like damage within cells.
Simultaneously, cells can enter a state called cellular senescence, where they stop dividing but remain active, often releasing substances that can cause inflammation and damage to surrounding healthy tissue. Think of these as “zombie cells” that refuse to die and instead cause trouble.
This accelerated aging, driven by faulty mitochondria and senescent cells, creates a cascade of events in gestational tissues. It promotes inflammation, alters the structure of tissues, and triggers hormonal changes that collectively push the body towards premature labor.
Understanding early birth through this lens of accelerated gestational aging offers a fresh framework for researchers and doctors. It opens doors for developing new ways to identify women at risk and to create targeted treatments, such as therapies that support mitochondrial health or remove senescent cells, ultimately aiming to reduce the global burden of prematurity.
Source: link to paper